-+ 0.00%
-+ 0.00%
-+ 0.00%

ABBVIE EXEC SAYS EXPECTS APPROVAL OF SUBCUTANEOUS CROHN'S DISEASE TREATMENT IN Q4 - CONF CALL

路透·09/09/2026 14:25:43

登錄查看新聞詳情